39
Views
6
CrossRef citations to date
0
Altmetric
Original Research

UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis

, &
Pages 5303-5309 | Published online: 06 Nov 2017

References

  • BenaventeCADyerMAGenetics and epigenetics of human retinoblastomaAnnu Rev Pathol20151054756225621664
  • AbramsonDHShieldsCLMunierFLChantadaGLTreatment of retinoblastoma in 2015: agreement and disagreementJAMA Ophthalmol2015133111341134726378747
  • HemminkiKChenBFamilial risks for eye melanoma and retinoblastoma: results from the Swedish Family-Cancer DatabaseMelanoma Res2015162191195
  • SeregardSSinghADRetinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavityBr J Ophthalmol201296447347422421997
  • IngrassiaLLefrancFKissRMijatovicTNaphthalimides and azonafides as promising anti-cancer agentsCurr Med Chem200916101192121319355879
  • BrañaMFCachoMGarcíaMANew analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding propertiesJ Med Chem20044761391139914998328
  • ZhangGAnYLuXA novel naphthalimide compound restores p53 function in non-small-cell lung cancer by reorganizing the Bak-Bcl-xl complex and triggering transcriptional regulationJ Biol Chem201629184211422526668309
  • MijatovicTMahieuTBruyèreCUNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancersNeoplasia200810657358618516294
  • ChenQDeadyLWBaguleyBCDennyWAElectron-deficient DNA intercalating agents as antitumor drugs: Aza analogs of the experimental clinical agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamideJ Med Chem19943755935978126699
  • GellermanGRecent developments in the synthesis and applications of anticancer amonafide derivatives: a mini reviewLett Drug Des Discov20161314763
  • BrañaMFCastellanoJMRoldánCMSantosAVázquezDJiménezASynthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8 naphthalic acidCancer Chemother Pharmacol19804161666153938
  • WaringMJGonzálezAJiménezAVázquezDIntercalative binding to DNA of antitumour drugs derived from 3-nitro-1,8-naphthalic acidNucleic Acids Res197971217230573892
  • CasadoARosellRGarcía-GómezRPhase II study of mitonafide in non-small cell lung cancer (NSCLC)Invest New Drugs19961444154179157079
  • MalviyaVKLiuPYAlbertsDSSurwitEACraigJBHanniganEVEvaluation of amonafide in cervical cancer, phase II: a SWOG studyAm J Clin Oncol199215141441550078
  • MahieuTMijatovicTQuaquebekeEVUNBS5162 is a novel naphthalimide derivative that induces autophagy and senescence in human prostate cancer cellsMol Cancer Ther20076123373S
  • SluntKMGraceJMMacdonaldTLPearsonRDEffect of mitonafide analogs on topoisomerase II of Leishmania chagasiAntimicrob Agents Chemother19964037067098851597
  • MijatovicTMahieuTBruyèreCUNBS5162, CXCL, prostate cancerNeoplasia200810657358618516294
  • DholakiaASKumarRRamanSPMapping patterns of local failure after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field designInt J Radiat Oncol Biol Phys20138751007101524267969
  • WangZSunJFengYTianXWangBZhouYOncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cellTumour Biol20163778515852827079871
  • MahadevanDNorthfeltDWChalasaniPPhase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphomaInt J Clin Oncol201318593494123053399
  • RossiDZlotnikAThe biology of chemokines and their receptorsAnnu Rev Immunol20001821724210837058
  • KothurKWienholtLBrilotFDaleRCCSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic reviewCytokine20167722723726463515
  • ReilandJFurchtLTMcCarthyJBCXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptorProstate20154127888
  • XuLKitadeHNiYOtaTRoles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver diseaseBiomolecules2015531563157926197341
  • GuanXHFuQCShiDActivation of spinal chemokine receptor CXCR3 mediates bone cancer pain through an Akt-ERK crosstalk pathway in ratsExp Neurol2015263394925281485
  • ImaiHSunagaNShimizuYClinicopathological and therapeutic significance of CXCL12 expression in lung cancerInt J Immunopathol Pharmacol2015231153164
  • GuoFWangYLiuJMokSCXueFZhangWCXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networksOncogene201635781682625961926
  • TotonchyJEOsbornJMBottoSClepperLMosesAVAberrant proliferation in CXCR7+ endothelial cells via degradation of the retinoblastoma proteinPLoS One201387e6982823894550
  • KhanMZBrandimartiRShimizuSNicolaiJCroweEMeucciOThe chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb proteinCell Death Differ200815101663167218583990